Stocks · News reference
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $5
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Tumbles 450 Points; US Small Business Sentiment Declines In August
U.S. stocks fell Tuesday, led by a 450-point Dow drop; health care slid while energy rose. NFIB optimism weakened, oil and copper gained.
PDS Biotechnology shares are trading higher after the company announced it raised up to $22.55 million in equity funding in a Private Investment in Public Equity transaction.